143 related articles for article (PubMed ID: 30137206)
1. KLK6 protease accelerates skin tumor formation and progression.
Khoury N; Zingkou E; Pampalakis G; Sofopoulos M; Zoumpourlis V; Sotiropoulou G
Carcinogenesis; 2018 Dec; 39(12):1529-1536. PubMed ID: 30137206
[TBL] [Abstract][Full Text] [Related]
2. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
4. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
7. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
8. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.
Kishibe M; Baida G; Bhalla P; Lavker RM; Schlosser B; Iinuma S; Yoshida S; Dudley JT; Budunova I
Oncotarget; 2016 Oct; 7(43):69479-69488. PubMed ID: 27283773
[TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
10. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
12. The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
Hoesl C; Fröhlich T; Hundt JE; Kneitz H; Goebeler M; Wolf R; Schneider MR; Dahlhoff M
Mol Oncol; 2019 Nov; 13(11):2476-2492. PubMed ID: 31580518
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.
Robertson FM; Ross MS; Tober KL; Long BW; Oberyszyn TM
Carcinogenesis; 1996 Aug; 17(8):1719-28. PubMed ID: 8761432
[TBL] [Abstract][Full Text] [Related]
14. Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.
Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T
Carcinogenesis; 2001 Nov; 22(11):1837-41. PubMed ID: 11698347
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
16. A proinflammatory role of KLK6 protease in Netherton syndrome.
Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
[TBL] [Abstract][Full Text] [Related]
18. Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
Winter M; Lodygin D; Verdoodt B; Hermeking H
Oncotarget; 2016 Jul; 7(30):46862-46870. PubMed ID: 27409835
[TBL] [Abstract][Full Text] [Related]
19. CENP-R acts bilaterally as a tumor suppressor and as an oncogene in the two-stage skin carcinogenesis model.
Okumura K; Kagawa N; Saito M; Yoshizawa Y; Munakata H; Isogai E; Fukagawa T; Wakabayashi Y
Cancer Sci; 2017 Nov; 108(11):2142-2148. PubMed ID: 28795467
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
